Status:
COMPLETED
Evaluating Two Exercise Training Programs to Reduce Leg Pain in People With Peripheral Arterial Disease (The EXERT Study)
Lead Sponsor:
University of Minnesota
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Intermittent Claudication
Peripheral Vascular Diseases
Eligibility:
All Genders
18-90 years
Phase:
PHASE3
Brief Summary
Peripheral arterial disease (PAD) is a disorder that affects more than 8 million people in the United States. As a result of decreased blood flow to the legs, people with PAD may experience leg pain a...
Detailed Description
PAD is a condition that occurs when atherosclerotic plaque builds up in the peripheral arteries and restricts blood flow. People with PAD often experience reduced blood flow to the legs, which may cau...
Eligibility Criteria
Inclusion
- Has lifestyle-limiting claudication
- Able to walk on a treadmill at 2 mph
- Able to perform arm ergometry exercise
- Able to complete a 12-week exercise program
Exclusion
- Physical activities are limited for reasons other than claudication
- Uncontrolled high blood pressure
- Uncontrolled diabetes
- Unstable coronary heart disease
- Ischemic rest pain or tissue loss
- Recent (in the 3 months before study entry) coronary or peripheral revascularization
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT00895635
Start Date
January 1 2009
End Date
April 1 2014
Last Update
November 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455